Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D09AZO
|
||||
Former ID |
DNC006878
|
||||
Drug Name |
4-(3-methylpyridin-2-yl)-N-p-tolylbenzamide
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [528334] | ||
Structure |
Download2D MOL |
||||
Formula |
C20H18N2O
|
||||
Canonical SMILES |
CC1=CC=C(C=C1)NC(=O)C2=CC=C(C=C2)C3=C(C=CC=N3)C
|
||||
InChI |
1S/C20H18N2O/c1-14-5-11-18(12-6-14)22-20(23)17-9-7-16(8-10-17)19-15(2)4-3-13-21-19/h3-13H,1-2H3,(H,22,23)
|
||||
InChIKey |
ACHPKRXTLZWRLG-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Vanilloid receptor 1 | Target Info | Inhibitor | [528334] | |
NetPath Pathway | IL2 Signaling Pathway | ||||
Pathway Interaction Database | Trk receptor signaling mediated by the MAPK pathway | ||||
Trk receptor signaling mediated by PI3K and PLC-gamma | |||||
Reactome | TRP channels | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.